These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 14643999)
41. Significance of combined use of MRI and perfusion SPECT for evaluation of multiple system atrophy, cerebellar type. Miyoshi F; Kanasaki Y; Shinohara Y; Fujii S; Kaminou T; Tanabe Y; Ogawa T Acta Radiol; 2016 Jun; 57(6):742-9. PubMed ID: 26253930 [TBL] [Abstract][Full Text] [Related]
42. Voxel-based morphometry and Voxel-based relaxometry in parkinsonian variant of multiple system atrophy. Tzarouchi LC; Astrakas LG; Konitsiotis S; Tsouli S; Margariti P; Zikou A; Argyropoulou MI J Neuroimaging; 2010 Jul; 20(3):260-6. PubMed ID: 19187475 [TBL] [Abstract][Full Text] [Related]
43. Comparison of brain MRI and 18F-FDG PET in the differential diagnosis of multiple system atrophy from Parkinson's disease. Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ Mov Disord; 2007 Dec; 22(16):2352-8. PubMed ID: 17894342 [TBL] [Abstract][Full Text] [Related]
44. Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy. Ito M; Watanabe H; Kawai Y; Atsuta N; Tanaka F; Naganawa S; Fukatsu H; Sobue G J Neurol Neurosurg Psychiatry; 2007 Jul; 78(7):722-8. PubMed ID: 17353258 [TBL] [Abstract][Full Text] [Related]
45. Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. Bhattacharya K; Saadia D; Eisenkraft B; Yahr M; Olanow W; Drayer B; Kaufmann H Arch Neurol; 2002 May; 59(5):835-42. PubMed ID: 12020268 [TBL] [Abstract][Full Text] [Related]
47. Longitudinal MRI study of multiple system atrophy - when do the findings appear, and what is the course? Horimoto Y; Aiba I; Yasuda T; Ohkawa Y; Katayama T; Yokokawa Y; Goto A; Ito Y J Neurol; 2002 Jul; 249(7):847-54. PubMed ID: 12140668 [TBL] [Abstract][Full Text] [Related]
48. Imaging of olfactory bulb and gray matter volumes in brain areas associated with olfactory function in patients with Parkinson's disease and multiple system atrophy. Chen S; Tan HY; Wu ZH; Sun CP; He JX; Li XC; Shao M Eur J Radiol; 2014 Mar; 83(3):564-70. PubMed ID: 24360232 [TBL] [Abstract][Full Text] [Related]
49. Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease. Barbagallo G; Sierra-Peña M; Nemmi F; Traon AP; Meissner WG; Rascol O; Péran P Mov Disord; 2016 Mar; 31(3):325-34. PubMed ID: 26676922 [TBL] [Abstract][Full Text] [Related]
50. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy]. Lass P; Sławek J; Derejko M; Dubaniewicz M Neurol Neurochir Pol; 2003; 37 Suppl 5():263-74. PubMed ID: 15098354 [TBL] [Abstract][Full Text] [Related]
51. Cognitive event-related potentials in multiple sclerosis: Correlation with MRI and neuropsychological findings. Kimiskidis VK; Papaliagkas V; Sotirakoglou K; Kouvatsou ZK; Kapina VK; Papadaki E; Tsimourtou V; Masoura E; Kazis DA; Papayiannopoulos S; Geroukis T; Bostanjopoulou S Mult Scler Relat Disord; 2016 Nov; 10():192-197. PubMed ID: 27919489 [TBL] [Abstract][Full Text] [Related]
52. [An autopsied case of multiple system atrophy with remarkable cerebral atrophy]. Konagaya M; Sakai M; Matsuoka Y; Goto Y; Hashizume Y Rinsho Shinkeigaku; 1998 Jul; 38(7):673-9. PubMed ID: 9868315 [TBL] [Abstract][Full Text] [Related]
53. Linking hemodynamic and electrophysiological measures of brain activity: evidence from functional MRI and intracranial field potentials. Huettel SA; McKeown MJ; Song AW; Hart S; Spencer DD; Allison T; McCarthy G Cereb Cortex; 2004 Feb; 14(2):165-73. PubMed ID: 14704213 [TBL] [Abstract][Full Text] [Related]
54. The putaminal abnormalities on 3.0T magnetic resonance imaging: can they separate parkinsonism-predominant multiple system atrophy from Parkinson's disease? Feng JY; Huang B; Yang WQ; Zhang YH; Wang LM; Wang LJ; Zhong XL Acta Radiol; 2015 Mar; 56(3):322-8. PubMed ID: 24619850 [TBL] [Abstract][Full Text] [Related]
55. Visualization and quantification of disease progression in multiple system atrophy. Hauser TK; Luft A; Skalej M; Nägele T; Kircher TT; Leube DT; Schulz JB Mov Disord; 2006 Oct; 21(10):1674-81. PubMed ID: 16830312 [TBL] [Abstract][Full Text] [Related]
56. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Schocke MF; Seppi K; Esterhammer R; Kremser C; Jaschke W; Poewe W; Wenning GK Neurology; 2002 Feb; 58(4):575-80. PubMed ID: 11865135 [TBL] [Abstract][Full Text] [Related]
57. State and trait markers of emotionally charged visual event-related potentials (P300) in drug-naïve schizophrenia. Mori K; Morita K; Shoji Y; Matsuoka T; Fujiki R; Uchimura N Psychiatry Clin Neurosci; 2012 Jun; 66(4):261-9. PubMed ID: 22624730 [TBL] [Abstract][Full Text] [Related]
58. Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy. Asato R; Akiguchi I; Masunaga S; Hashimoto N J Neural Transm (Vienna); 2000; 107(12):1427-36. PubMed ID: 11458995 [TBL] [Abstract][Full Text] [Related]
59. A randomized trial of mesenchymal stem cells in multiple system atrophy. Lee PH; Lee JE; Kim HS; Song SK; Lee HS; Nam HS; Cheong JW; Jeong Y; Park HJ; Kim DJ; Nam CM; Lee JD; Kim HO; Sohn YH Ann Neurol; 2012 Jul; 72(1):32-40. PubMed ID: 22829267 [TBL] [Abstract][Full Text] [Related]
60. Characteristic MRI findings in multiple system atrophy: comparison of the three subtypes. Naka H; Ohshita T; Murata Y; Imon Y; Mimori Y; Nakamura S Neuroradiology; 2002 Mar; 44(3):204-9. PubMed ID: 11942373 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]